The Executive Guide to Reducing Claim Denials with Agentic AI

Premier Inc. estimates that U.S. health systems face $262 billion in potentially avoidable denials each year. That figure, striking on its own, understates the operational burden: denied claims consume staff time for rework, delay cash flow by weeks or months, and often end in write-offs when teams lack the capacity to appeal.

The MGMA benchmarks further illustrate the cost. The average clinical denial requires 118 hours of RN time to overturn on appeal. That is time drawn from scarce clinical staff who could otherwise be supporting patient care. Yet roughly 65% of denied claims are never reworked at all, meaning the potential recovery simply disappears.

Several forces are pushing denial rates higher simultaneously:

• Payer policy complexity: Prior authorization requirements and medical necessity criteria change continuously. Rules that applied last quarter may not apply today, and no static rule set can keep pace.
• Coding and documentation gaps: Diagnosis coding errors, insufficient documentation specificity, and mismatched modifier usage are among the most common denial triggers, yet they remain difficult to catch at scale before claims leave the building.
• Staff turnover in revenue cycle: Experienced coders and denial specialists carry institutional knowledge that is hard to transfer and easy to lose when they leave.
• Claim volume growth: As patient volumes recover post-pandemic and value-based contract complexity increases, the sheer number of claims requiring review outpaces manual capacity.

The average clinical denial requires 118 hours of RN time to overturn. Sixty-five percent of denied claims are never reworked at all.

The result is a system under structural pressure: high denial rates, limited rework capacity, and escalating write-offs. Incremental process improvements have not solved the problem because they address symptoms rather than root causes.

Revenue cycle leaders have invested heavily in automation over the past decade. Robotic process automation bots handle repetitive portal tasks. Denial management modules within EHR platforms flag claims for review. Business intelligence dashboards track denial rates by payer and code. Each tool addressed a real gap at the time it was deployed.

The core limitation of each is the same: they execute fixed instructions on known inputs. When payers change portal structures, bots break. When a new denial category emerges, the rules engine has no response until a developer writes a new rule. When denial data is analyzed in a BI dashboard, the insight arrives weeks after the claim was submitted.

Three structural gaps remain unaddressed by the current generation of tools:

1. Reactive posture: Most denial management happens after the claim is denied. The rework and appeal cycle is expensive and slow. Prevention at the point of documentation or prior authorization is rarely automated at scale.
2. Brittle payer policy tracking: Payer policies exist in PDFs, portals, and LCD/NCD databases that change continuously. Translating policy changes into updated rules requires manual analyst work that introduces lag measured in weeks.
3. Fragmented data: The signals that predict denials span the EHR, the clearinghouse, the payer portal, and the denial management workflow. Legacy tools work within one system at a time and cannot correlate signals across the full claim lifecycle.

The consequence is that organizations run expensive denial management programs that produce marginal improvement year over year. Staff ratios increase, work queues grow, and appeal win rates plateau.

Agentic AI refers to AI systems that can observe context, reason about a goal, take sequences of actions across multiple tools, and learn from feedback without requiring a developer to write a new rule for each new situation. Applied to denial management, this unlocks three capabilities that prior generations of automation could not deliver.

Prevention at the point of order

An agentic system working alongside clinical documentation can review a proposed order or note against current payer medical necessity criteria in real time. It surfaces issues before the claim is submitted, not after it is denied. This shifts the cost curve fundamentally: a brief intervention at documentation is far less expensive than 118 hours of RN rework on appeal.

Continuous payer policy awareness

Rather than relying on a quarterly rules update cycle, an agentic system can continuously monitor payer LCD/NCD updates, portal policy changes, and proprietary payer bulletins. When a policy changes, the system updates its reasoning accordingly, without requiring a developer to write new rules or a scheduler to manually refresh a database.

Autonomous root-cause analysis and routing

When a claim is denied, an agentic system can analyze the denial reason code, cross-reference the clinical record and documentation, determine the most likely root cause, and route the claim to the appropriate workflow. High-confidence appeals can be drafted autonomously. Claims requiring clinical review are escalated with context already assembled, reducing the time a denial specialist spends before taking action.

Agentic AI does not replace the denial management team. It changes the work: from reactive rework to proactive prevention, from manual research to AI-assisted appeal.

Together, these capabilities shift the operating model from a reactive, labor-intensive rework queue to a proactive, learning system that improves as it operates. The strategic outcome is what revenue cycle leaders have begun calling a touchless revenue cycle: one where routine work happens autonomously and human expertise concentrates on judgment calls that genuinely require it.

Most health systems that implement agentic AI for denial management do so in three phases. The phases can be compressed or expanded based on organizational readiness, IT capacity, and payer mix complexity.

The three-phase structure is a starting point, not a mandate. Organizations with mature RCM programs and clean denial data often compress phases one and two. Organizations still building foundational data infrastructure may extend phase one. Staff freed from routine denial rework become available for higher-leverage revenue cycle work: contract analysis, payer relationship management, patient financing support, and financial assistance screening.

Revenue cycle leaders who have approved agentic AI programs, including those who have worked directly with the ArceeHQ team, describe two common challenges in building the business case: selecting the right baseline metrics and projecting outcomes without overstating them.

The most defensible business case framework anchors to current baseline performance and projects improvement across three areas:

Present projections in a range, not a point estimate. A best-case and base-case scenario with explicit assumptions is more credible than a single number. Your CFO will ask what assumptions you made; have them ready.

The CFO conversation goes better when you lead with the baseline cost of inaction: $Y in annual write-offs, Z FTE hours per week on denial rework. That is the counterfactual the board needs to evaluate the investment.

A common mistake is building the business case exclusively around appeal revenue recovery. The larger opportunity in most health systems is prevention: claims that never get denied cost nothing to rework. Frame the case around the total cost of the denial problem, not just recoverable denial revenue.

Our EHR vendor is already building this. Why not wait?

EHR vendors are building AI-assisted coding and denial features, and some are genuinely useful for straightforward cases. The gap is payer-specific policy intelligence and multi-system reasoning. EHR-native tools operate on the clinical record; they typically do not continuously monitor payer policy changes or correlate clearinghouse denial patterns across your full claim volume. Purpose-built agentic systems do both.

We do not have clean data. Can we still start?

A structured denial data audit is part of Phase One precisely because most organizations do not have clean data when they start. The audit does not need to be perfect; it needs to establish a defensible baseline for your highest-volume denial categories. Clean data is built as part of the program, not a prerequisite for it.

How do we handle payer contract confidentiality and data security?

Agentic AI systems operating in healthcare settings are designed to work within existing data governance frameworks. Claim data does not need to leave your environment for the system to function. Your HIPAA and payer contract obligations are unchanged.

Will clinical staff trust AI recommendations on prior auth?

The workflow is designed for human review, not autonomous clinical decision-making. The AI surfaces documentation gaps and policy requirements; the clinician reviews and acts. In practice, adoption resistance from clinical staff tends to decrease once the system demonstrates accuracy on their specialty’s most common denial patterns.

What happens when a payer changes a policy the AI does not know about yet?

Continuous payer policy monitoring is a core capability of the system. The monitoring covers LCD/NCD databases, payer bulletins, and portal policy pages for your contracted payers. When a policy changes, the system flags the change and updates its reasoning. Detection lag is hours to days, not the weeks or months typical of manual policy update cycles.